Bd. Sohl et al., Utility of minor ultrasonographic markers in the prediction of abnormal fetal karyotype at a prenatal diagnostic center, AM J OBST G, 181(4), 1999, pp. 898-903
OBJECTIVE: This study was undertaken to assess the value of minor ultrasono
graphic markers in predicting significant karyotypic abnormalities.
STUDY DESIGN: A total of 2743 fetuses (14-24 weeks' gestation) prospectivel
y underwent a detailed ultrasonographic survey before genetic amniocentesis
. Criteria for 8 minor ultrasonographic markers were established. Odds rati
os for significant karyotypic abnormalities in the presence of minor ultras
onographic markers were calculated with the chi 2 and Fisher exact tests.
RESULTS: Of the fetuses, 14.6% had a single minor ultrasonographic marker,
2.1% had greater than or equal to 2 minor ultrasonographic markers, and 2.7
% had greater than or equal to 1 major ultrasonographic abnormality One hun
dred four fetuses (3.8%) had an abnormal karyotype. Compared with a normal
ultrasonographic examination result a single minor ultrasonographic marker
increased the risk of karyotypic abnormality 5.7-fold (95% confidence inter
val, 3.5-9.3), whereas multiple minor markers increased the risk of an abno
rmal karyotype 12-fold (95% confidence interval, 5.5-26.5). When they were
identified ultrasonographically in isolation, echogenic bowel, 2-vessel umb
ilical cord. echogenic intracardiac foci, choroidal separation, and choroid
plexus cysts were statistically associated with an abnormal karyotype. Whe
n minor markers were identified in clusters of greater than or equal to 2,
echogenic bowel, short femur, 2-vessel umbilical cord, echogenic intracardi
ac foci, and mild ventriculomegaly were significantly predictive of karyoty
pic abnormality. With respect to the a priori aneuploidy risk of 1:26 and t
he a priori Down syndrome risk of 1:50, a normal ultrasonographic examinati
on result reduced the risks to 1:67 and 1:120, respectively. The use of min
or ultrasonographic markers in addition to major ultrasonographic abnormali
ties increased the detection of karyotypic abnormality from 27.9% to 68.3%.
For trisomy 21 the sensitivity rose from 16.4% to 67.3%.
CONCLUSIONS: Significant karyotypic abnormality risk assessment by ultrason
ography was greatly enhanced by the addition of minor ultrasonographic mark
ers. Further, clusters of minor ultrasonographic markers greatly increased
the likelihood of karyotypic abnormality compared with a single minor marke
r. A completely normal ultrasonographic examination result reduced the risk
of an abnormal karyotype by 62%. inclusion of minor ultrasonographic marke
rs in the genetic sonogram in a high-risk population will allow the detecti
on of 68% of fetuses with karyotypic abnormalities with a false-positive ra
te of 17%.